ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ionis and Akcea to Collaborate with Novartis to Develop and AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx
February 20, 2017Ionis Pharmaceuticals and Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, Inc., have closed on their exclusive, worldwide option and collaboration agreement with Novartis to develop and commercialize AKCEA-APO(a)-LRx and AKCEA-APOC
Pharma Sources Insight January 2025
